UK stocks seen higher as AstraZeneca, inflation and oil in focus

FTSE 100 futures were up 0.1%. Reuters highlighted AstraZeneca's $2 billion investment in Summit Therapeutics, slower UK shop price inflation and firmer oil and gold.